|
1
|
Huppa JB and Davis MM: The
interdisciplinary science of T-cell recognition. Adv Immunol.
119:1–50. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Schildberg FA, Klein SR, Freeman GJ and
Sharpe AH: Coinhibitory pathways in the B7-CD28 ligand-receptor
family. Immunity. 44:955–972. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen L and Flies DB: Molecular mechanisms
of T cell co- stimulation and co-inhibition. Nat Rev Immunol.
13:227–242. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Keir ME, Butte MJ, Freeman GJ and Sharpe
AH: PD-1 and its ligands in tolerance and immunity. Annu Rev
Immunol. 26:677–704. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Salomon B and Bluestone JA: Complexities
of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and
transplantation. Annu Rev Immunol. 19:225–252. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sica GL, Choi IH, Zhu G, Tamada K, Wang
SD, Tamura H, Chapoval AI, Flies DB, Bajorath J and Chen L: B7-H4 a
molecule of the B7 family, negatively regulates T cell immunity.
Immunity. 18:849–861. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Prasad DV, Richards S, Mai XM and Dong C:
B7S1, a novel B7 family member that negatively regulates T cell
activation. Immunity. 18:863–873. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Salceda S, Tang T, Kmet M, Munteanu A,
Ghosh M, Macina R, Liu W, Pilkington G and Papkoff J: The
immunomodulatory protein B7-H4 is overexpressed in breast and
ovarian cancers and promotes epithelial cell transformation. Exp
Cell Res. 306:128–141. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Afreen S and Dermime S: The
immunoinhibitory B7-H1 molecule as a potential target in cancer:
Killing many birds with one stone. Hematol Oncol Stem Cell Ther.
7:1–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tringler B, Zhuo S, Pilkington G, Torkko
KC, Singh M, Lucia MS, Heinz DE, Papkoff J and Shroyer KR: B7-h4 is
highly expressed in ductal and lobular breast cancer. Clin Cancer
Res. 11:1842–1848. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xie N, Cai JB, Zhang L, Zhang PF, Shen YH,
Yang X, Lu JC, Gao DM, Kang Q, Liu LX, et al: Upregulation of B7-H4
promotes tumor progression of intrahepatic cholangiocarcinoma. Cell
Death Dis. 8:32052017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Abadi YM, Jeon H, Ohaegbulam KC,
Scandiuzzi L, Ghosh K, Hofmeyer KA, Lee JS, Ray A, Gravekamp C and
Zang X: Host b7x promotes pulmonary metastasis of breast cancer. J
Immunol. 190:3806–3814. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang H, Li C and Ren G: Clinical
significance of the B7-H4 as a novel prognostic marker in breast
cancer. Gene. 623:24–28. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Franchina DG, He F and Brenner D: Survival
of the fittest: Cancer challenges T cell metabolism. Cancer Lett.
412:216–223. 2018. View Article : Google Scholar
|
|
15
|
Ni L and Dong C: New B7 family checkpoints
in human cancers. Mol Cancer Ther. 16:1203–1211. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pardoll DM: The blockade of immune
checkpoints in cancer immunotherapy. Nat Rev Cancer. 12:252–264.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Podojil JR and Miller SD: Potential
targeting of B7-H4 for the treatment of cancer. Immunol Rev.
276:40–51. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vogt AB, Spindeldreher S and Kropshofer H:
Clustering of MHC-peptide complexes prior to their engagement in
the immunological synapse: Lipid raft and tetraspan microdomains.
Immunol Rev. 189:136–151. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rees JS, Li XW, Perrett S, Lilley KS and
Jackson AP: Protein neighbors and proximity proteomics. Mol Cell
Proteomics. 14:2848–2856. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li XW, Rees JS, Xue P, Zhang H, Hamaia SW,
Sanderson B, Funk PE, Farndale RW, Lilley KS, Perrett S and Jackson
AP: New insights into the DT40 B cell receptor cluster using a
proteomic proximity labeling assay. J Biol Chem. 289:14434–14447.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rees JS, Li XW, Perrett S, Lilley KS and
Jackson AP: Selective proteomic proximity labeling assay using
tyramide (SPPLAT): A quantitative method for the proteomic analysis
of localized membrane-bound protein clusters. Curr Protoc Protein
Sci. 88:19.27.1–19.27.18. 2017. View Article : Google Scholar
|
|
22
|
Neve RM, Chin K, Fridlyand J, Yeh J,
Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, et al: A
collection of breast cancer cell lines for the study of
functionally distinct cancer subtypes. Cancer Cell. 10:515–527.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hamaia SW, Pugh N, Raynal N, Némoz B,
Stone R, Gullberg D, Bihan D and Farndale RW: Mapping of potent and
specific binding motifs, GLOGEN and GVOGEA, for integrin
alpha-1beta1 using collagen toolkits II and III. J Biol Chem.
287:26019–26028. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li X, Liu CX, Xue W, Zhang Y, Jiang S, Yin
QF, Wei J, Yao RW, Yang L and Chen LL: Coordinated circRNA
biogenesis and function with NF90/NF110 in viral infection. Mol
Cell. 67:214–227.e7. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ziegler YS, Moresco JJ, Tu PG, Yates JR
III and Nardulli AM: Plasma membrane proteomics of human breast
cancer cell lines identifies potential targets for breast cancer
diagnosis and treatment. PLoS One. 9:e1023412014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pozzi A, Wary KK, Giancotti FG and Gardner
HA: Integrin alpha1beta1 mediates a unique collagen-dependent
proliferation pathway in vivo. J Cell Biol. 142:587–594. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Meyer T, Marshall JF and Hart IR:
Expression of alphav integrins and vitronectin receptor identity in
breast cancer cells. Br J Cancer. 77:530–536. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schaffner F, Ray AM and Dontenwill M:
Integrin alpha5beta1, the fibronectin receptor, as a pertinent
therapeutic target in solid tumors. Cancers (Basel). 5:27–47. 2013.
View Article : Google Scholar
|
|
29
|
Rieger L, Hofmeister V, Probe C, Dietl J,
Weiss EH, Steck T and Kämmerer U: Th1- and Th2-like cytokine
production by first trimester decidual large granular lymphocytes
is influenced by HLA-G and HLA-E. Mol Hum Reprod. 8:255–261. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Podojil JR, Chiang MY, Ifergan I, Copeland
R, Liu LN, Maloveste S, Langermann S, Liebenson D, Balabanov R, Chi
H, et al: B7-H4 modulates regulatory CD4+ T cell
induction and function via ligation of a semaphorin 3a/Plexin
A4/Neuropilin-1 complex. J Immunol. 201:897–907. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu W, Goncalves KA, Li S, Kishikawa H, Sun
G, Yang H, Vanli N, Wu Y, Jiang Y, Hu MG, et al: Plexin-B2 mediates
physiologic and pathologic functions of angiogenin. Cell.
171:849–864.e25. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Landouré G, Knight MA, Stanescu H, Taye
AA, Shi Y, Diallo O, Johnson JO, Hernandez D, Traynor BJ, Biesecker
LG, et al: A candidate gene for autoimmune myasthenia gravis.
Neurology. 79:342–347. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Maldonado-Montoro M, Cañadas-Garre M,
González-Utrilla A, Plaza-Plaza JC and Calleja-Hernández MŸ:
Genetic and clinical biomarkers of tocilizumab response in patients
with rheumatoid arthritis. Pharmacol Res. 111:264–271. 2016.
View Article : Google Scholar : PubMed/NCBI
|
